"Colitis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
Descriptor ID |
D003092
|
MeSH Number(s) |
C06.405.205.265 C06.405.469.158.188
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Colitis".
Below are MeSH descriptors whose meaning is more specific than "Colitis".
This graph shows the total number of publications written about "Colitis" by people in this website by year, and whether "Colitis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 2 | 0 | 2 |
2000 | 1 | 1 | 2 |
2003 | 0 | 1 | 1 |
2004 | 3 | 0 | 3 |
2005 | 2 | 1 | 3 |
2006 | 1 | 1 | 2 |
2007 | 6 | 4 | 10 |
2008 | 4 | 1 | 5 |
2009 | 6 | 3 | 9 |
2010 | 2 | 3 | 5 |
2011 | 4 | 0 | 4 |
2012 | 6 | 1 | 7 |
2013 | 4 | 3 | 7 |
2014 | 4 | 2 | 6 |
2015 | 9 | 1 | 10 |
2016 | 5 | 2 | 7 |
2017 | 2 | 2 | 4 |
2018 | 9 | 2 | 11 |
2019 | 6 | 5 | 11 |
2020 | 8 | 2 | 10 |
2021 | 10 | 2 | 12 |
2022 | 14 | 1 | 15 |
2023 | 4 | 0 | 4 |
2024 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Colitis" by people in Profiles.
-
Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis. J Exp Med. 2024 Jun 03; 221(6).
-
An interesting endoscopic presentation of fecal stream diversion colitis. J Pediatr Gastroenterol Nutr. 2024 Apr; 78(4):996-997.
-
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series. J Immunother Cancer. 2024 01 31; 12(1).
-
Prevalence of Enteric Infections in Patients on Immune Checkpoint Inhibitors and Impact on Management and Outcomes. Oncologist. 2024 Jan 05; 29(1):36-46.
-
Tregs protect against invariant NKT cell-mediated autoimmune colitis and hepatitis. Immunology. 2024 Feb; 171(2):277-285.
-
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis. Sci Transl Med. 2023 06 14; 15(700):eabq4006.
-
Enhancing oral delivery of plant-derived vesicles for colitis. J Control Release. 2023 05; 357:472-483.
-
High levels of fecal calprotectin and C-reactive protein in patients with colitis. J Med Life. 2023 Jan; 16(1):48-51.
-
Implementing an immunotherapy toxicity (IOTOX) GI service improves outcomes in patients with immune-mediated diarrhea and colitis. J Cancer Res Clin Oncol. 2023 Aug; 149(9):5841-5852.
-
Characteristics and outcomes of cancer patients with pre-existing microscopic colitis after exposure to PD-1 and PD-L1 inhibitors. J Cancer Res Clin Oncol. 2023 Jul; 149(8):5429-5436.